Alexander Bürkle
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Alexander Bürkle has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Ralph Meyer
Abteilung Tumorvirologie, Deutsches Krebsforschungszentrum, Heidelberg, Germany
2 shared publicationsSascha Beneke
Abteilung Tumorvirologie, Deutsches Krebsforschungszentrum, Heidelberg, Germany
2 shared publicationsAlan Leake
Department of Gerontology, Institute for Ageing and Health, Wolfson Research Centre, University of Newcastle, NGH, Westgate Road, IHE, Newcastle upon Tyne NE4 6BE, UK
1 shared publicationChristine Brabeck
Abteilung Tumorvirologie, Deutsches Krebsforschungszentrum, Heidelberg, Germany
1 shared publicationJan-Heiner Küpper
Deutsches Krebsforschungszentrum, Abteilung Tumorvirologie, Heidelberg, Germany
1 shared publicationMarcus Müller
Deutsches Krebsforschungszentrum, Abteilung Tumorvirologie, Heidelberg, Germany
1 shared publication
Latest Publications
- 17 September 2002
- Published by Elsevier in Experimental Gerontology
- Vol. 37 (10-11) , 1203-1205
Poly(ADP-ribose) polymerase-1, DNA repair and mammalian longevity
- 17 September 2002
- Published by Elsevier in Experimental Gerontology
- Vol. 37 (10-11) , 1203-1205
Poly(ADP-ribose) polymerase-1, DNA repair and mammalian longevity
- 30 April 2002
- Published by Elsevier in Mechanisms of Ageing and Development
- Vol. 123 (8) , 899-906
In memoriam Bernard Strehler—genomic instability in ageing: a persistent challenge
- 30 April 2002
- Published by Elsevier in Mechanisms of Ageing and Development
- Vol. 123 (8) , 899-906
In memoriam Bernard Strehler—genomic instability in ageing: a persistent challenge
- 28 September 2001
- Published by Wiley in ChemBioChem
- Vol. 2 (10) , 725-728
PARP-1: A Regulator of Genomic Stability Linked with Mammalian Longevity
- 28 September 2001
- Published by Wiley in ChemBioChem
- Vol. 2 (10) , 725-728
PARP-1: A Regulator of Genomic Stability Linked with Mammalian Longevity
Physiology and pathophysiology of poly(ADP‐ribosyl)ation *
One of the immediate eukaryotic cellular responses to DNA breakage is the covalent post‐translational modification of nuclear proteins with poly(ADP‐ribose) from NAD+ as precursor, mostly catalysed by poly(ADP‐ribose) polymerase‐1 (PARP‐1). Recently several other polypeptides have been shown to catalyse poly(ADP‐ribose) formation. Poly(ADP‐ribosyl)ation is involved in a variety of physiological and pathophysiological phenomena. Physiological functions include its participation in DNA‐base excision repair, DNA‐damage signalling, regulation of genomic stability, and regulation of transcription and proteasomal function, supporting the previously observed correlation of cellular poly(ADP‐ribosyl)ation capacity with mammalian life. The pathophysiology effects are mediated through PARP‐1 overactivity, which can cause cell suicide by NAD+ depletion. It is apparent that the latter effect underlies the pathogenesis of a wide range of disease states including type‐1 diabetes, ischaemic infarcts in various organs, and septic or haemorrhagic shock. Therefore pharmacological modulation of poly(ADP‐ribosyl)ation may prove to be an exciting option for various highly prevalent, disabling and even lethal diseases. BioEssays 23:795–806, 2001. © 2001 John Wiley & Sons, Inc.
Physiology and pathophysiology of poly(ADP‐ribosyl)ation *
One of the immediate eukaryotic cellular responses to DNA breakage is the covalent post‐translational modification of nuclear proteins with poly(ADP‐ribose) from NAD+ as precursor, mostly catalysed by poly(ADP‐ribose) polymerase‐1 (PARP‐1). Recently several other polypeptides have been shown to catalyse poly(ADP‐ribose) formation. Poly(ADP‐ribosyl)ation is involved in a variety of physiological and pathophysiological phenomena. Physiological functions include its participation in DNA‐base excision repair, DNA‐damage signalling, regulation of genomic stability, and regulation of transcription and proteasomal function, supporting the previously observed correlation of cellular poly(ADP‐ribosyl)ation capacity with mammalian life. The pathophysiology effects are mediated through PARP‐1 overactivity, which can cause cell suicide by NAD+ depletion. It is apparent that the latter effect underlies the pathogenesis of a wide range of disease states including type‐1 diabetes, ischaemic infarcts in various organs, and septic or haemorrhagic shock. Therefore pharmacological modulation of poly(ADP‐ribosyl)ation may prove to be an exciting option for various highly prevalent, disabling and even lethal diseases. BioEssays 23:795–806, 2001. © 2001 John Wiley & Sons, Inc.
- 1 May 2001
- Published by Springer Nature in Eye
- Vol. 15 (3) , 371-375
Mechanisms of ageing
Recent experimental work from a variety of biological systems, ranging from yeast to human beings, lends increasing support to the view that stochastic damage inflicted to biological macromolecules is the driving force for the ageing process. The damage is derived from small reactive molecules, most prominently reactive oxygen intermediates (ROD, that arise during normal cellular metabolism and are associated with important if not essential cellular functions. The major classes of macromolecules at risk are proteins, lipids and DNA, but damage to DNA (both nuclear and mitochondrial) may entail particularly severe consequences. Cellular dysfunction resulting from macromolecular damage can be detected as a variety of expressions, such as genomic instability, inappropriate cell differentiation events or cell death. While for post-mitotic cell types replacement of the dead cell by another cell of the same lineage is not possible, mitotic cell types may initially replace dead cells via cell proliferation. But exhaustion of the self-renewal capacity of the respective lineage, by either replication-associated or damage-associated telomere shortening, will ultimately also lead to loss of parenchymal cell mass and functional impairment of tissues, the latter being a typical feature of ageing of tissues and organs. It has been demonstrated in various experimental systems that the rate ageing of can be retarded by lowering the production of endogenous ROI or by improving cellular anti-oxidative defences. Whether augmentation of cellular DNA repair capacity will have the same effect remains to be seen.
- 1 May 2001
- Published by Springer Nature in Eye
- Vol. 15 (3) , 371-375
Mechanisms of ageing
Recent experimental work from a variety of biological systems, ranging from yeast to human beings, lends increasing support to the view that stochastic damage inflicted to biological macromolecules is the driving force for the ageing process. The damage is derived from small reactive molecules, most prominently reactive oxygen intermediates (ROD, that arise during normal cellular metabolism and are associated with important if not essential cellular functions. The major classes of macromolecules at risk are proteins, lipids and DNA, but damage to DNA (both nuclear and mitochondrial) may entail particularly severe consequences. Cellular dysfunction resulting from macromolecular damage can be detected as a variety of expressions, such as genomic instability, inappropriate cell differentiation events or cell death. While for post-mitotic cell types replacement of the dead cell by another cell of the same lineage is not possible, mitotic cell types may initially replace dead cells via cell proliferation. But exhaustion of the self-renewal capacity of the respective lineage, by either replication-associated or damage-associated telomere shortening, will ultimately also lead to loss of parenchymal cell mass and functional impairment of tissues, the latter being a typical feature of ageing of tissues and organs. It has been demonstrated in various experimental systems that the rate ageing of can be retarded by lowering the production of endogenous ROI or by improving cellular anti-oxidative defences. Whether augmentation of cellular DNA repair capacity will have the same effect remains to be seen.
- 1 February 2001
- Published by Elsevier in Cancer Letters
- Vol. 163 (1) , 1-5
Poly(APD-ribosyl)ation, a DNA damage-driven protein modification and regulator of genomic instability
- 1 February 2001
- Published by Elsevier in Cancer Letters
- Vol. 163 (1) , 1-5
Poly(APD-ribosyl)ation, a DNA damage-driven protein modification and regulator of genomic instability
- Open Access
- 17 October 2000
- Published by Wiley in International Journal of Cancer
- Vol. 88 (3) , 351-355
Negative regulation of alkylation-induced sister-chromatid exchange by poly(ADP-ribose) polymerase-1 activity
One of the earliest responses to DNA damage in eukaryotic cells is activation of poly(ADP‐ribose) polymerase‐1 (PARP‐1), a DNA strand break–dependent nuclear enzyme which covalently modifies proteins with poly(ADP‐ribose). Here, we show that conditional over‐expression of PARP‐1 in stably transfected hamster cells, which causes cellular over‐accumulation of poly(ADP‐ribose) by several‐fold, strongly suppresses alkylation‐induced sister‐chromatid exchange (SCE), while cytotoxicity of alkylation treatment is slightly enhanced. Viewed together with the known potentiation of SCE by abrogation of PARP‐1 activity, our results provide evidence that PARP‐1 activity is an important regulator of alkylation‐induced SCE formation, imposing a control that is strictly negative and commensurate with the level of enzyme activity. Int. J. Cancer 88:351–355, 2000.
- 17 October 2000
- Published by Wiley in International Journal of Cancer
- Vol. 88 (3) , 351-355
Open AccessNegative regulation of alkylation-induced sister-chromatid exchange by poly(ADP-ribose) polymerase-1 activity
One of the earliest responses to DNA damage in eukaryotic cells is activation of poly(ADP‐ribose) polymerase‐1 (PARP‐1), a DNA strand break–dependent nuclear enzyme which covalently modifies proteins with poly(ADP‐ribose). Here, we show that conditional over‐expression of PARP‐1 in stably transfected hamster cells, which causes cellular over‐accumulation of poly(ADP‐ribose) by several‐fold, strongly suppresses alkylation‐induced sister‐chromatid exchange (SCE), while cytotoxicity of alkylation treatment is slightly enhanced. Viewed together with the known potentiation of SCE by abrogation of PARP‐1 activity, our results provide evidence that PARP‐1 activity is an important regulator of alkylation‐induced SCE formation, imposing a control that is strictly negative and commensurate with the level of enzyme activity. Int. J. Cancer 88:351–355, 2000.
- 1 October 2000
- Published by Elsevier in Experimental Gerontology
- Vol. 35 (8) , 989-1002
Comparative characterisation of poly(ADP-ribose) polymerase-1 from two mammalian species with different life span
- 1 October 2000
- Published by Elsevier in Experimental Gerontology
- Vol. 35 (8) , 989-1002
Comparative characterisation of poly(ADP-ribose) polymerase-1 from two mammalian species with different life span
- 1 June 2000
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 908 (1) , 126-132
Poly(ADP‐Ribosyl)ation, Genomic Instability, and Longevity
Abstract: Poly(ADP‐ribosyl)ation is a DNA strandbreak‐driven posttranslational modification of nuclear proteins that is catalyzed by poly(ADP‐ribose) polymerase‐1 (PARP‐1), with NAD+ serving as substrate. Recently, additional PARP isoforms were described that seem to account for a minor fraction of cellular poly(ADP‐ribose) synthesis. We have previously described a correlation between poly(ADP‐ribosyl)ation capacity of mononuclear leukocytes of various mammalian species and species‐specific life span. Likewise, lymphoblastoid cell lines derived from human centenarians display a higher poly(ADP‐ribosyl)ation capacity than do controls. At the functional level, recent data show that PARP‐1 is a key regulator of alkylation‐induced sister‐chromatid exchange, imposing a negative control commensurate with the enzyme activity. PARP‐1 activity may therefore be responsible for tuning the rate of genomic instability events that are provoked by the constant attack of endogenous and exogenous genotoxins to a level appropriate for the longevity potential of a given organism or species.
- 1 June 2000
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 908 (1) , 126-132
Poly(ADP‐Ribosyl)ation, Genomic Instability, and Longevity
Abstract: Poly(ADP‐ribosyl)ation is a DNA strandbreak‐driven posttranslational modification of nuclear proteins that is catalyzed by poly(ADP‐ribose) polymerase‐1 (PARP‐1), with NAD+ serving as substrate. Recently, additional PARP isoforms were described that seem to account for a minor fraction of cellular poly(ADP‐ribose) synthesis. We have previously described a correlation between poly(ADP‐ribosyl)ation capacity of mononuclear leukocytes of various mammalian species and species‐specific life span. Likewise, lymphoblastoid cell lines derived from human centenarians display a higher poly(ADP‐ribosyl)ation capacity than do controls. At the functional level, recent data show that PARP‐1 is a key regulator of alkylation‐induced sister‐chromatid exchange, imposing a negative control commensurate with the enzyme activity. PARP‐1 activity may therefore be responsible for tuning the rate of genomic instability events that are provoked by the constant attack of endogenous and exogenous genotoxins to a level appropriate for the longevity potential of a given organism or species.